Rigel Pharmaceuticals(RIGL)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RIGL Rigel Pharmaceuticals

盘前交易 02-23 06:11:48 EST

35.46

-1.18

-3.22%

最高36.95	最低35.37	成交量35.45万
今开36.57	昨收36.64	日振幅4.33%
总市值6.44亿	流通市值5.78亿	总股本1,815万
成交额1,277万	换手率2.18%	流通股本1,630万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RIGL","market":"US","secType":"STK","nameCN":"Rigel Pharmaceuticals","latestPrice":35.46,"timestamp":1771621200000,"preClose":36.64,"halted":0,"volume":354546,"delay":0,"changeRate":-0.03220524017467248,"floatShares":16298699,"shares":18151344,"eps":6.196438,"marketStatus":"盘前交易","change":-1.18,"latestTime":"02-23 06:11:48 EST","open":36.57,"high":36.95,"low":35.365,"amount":12769030.91736,"amplitude":0.043259,"askPrice":43.96,"askSize":100,"bidPrice":30.18,"bidSize":100,"shortable":3,"etf":0,"ttmEps":6.196438,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771857000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":975474000000,"exchange":"NASDAQ","adjPreClose":35.46,"postHourTrading":{"tag":"盘后","latestPrice":36.4667,"preClose":35.46,"latestTime":"17:33 EST","volume":21881,"amount":776062.745,"timestamp":1771626781050,"change":1.0067,"changeRate":0.02839,"amplitude":0.02839},"volumeRatio":1.4368084869053859,"impliedVol":0.7828,"impliedVolPercentile":0.868},"requestUrl":"/m/hq/s/RIGL","defaultTab":"news","newsList":[{"id":"2607062053","title":"Rigel Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.02%报35.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607062053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607062053?lang=zh_cn&edition=full","pubTime":"2026-01-29 04:29","pubTimestamp":1769632195,"startTime":"0","endTime":"0","summary":"北京时间2026年01月29日04时29分，Rigel Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.02%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Jasper Therapeutics Inc C/Wts 24/09/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.涨幅较大，Gri Bio, Inc.、Calcimedica, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为2321.65%、299.42%、153.08%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Gri Bio, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为90.64%、53.19%、52.83%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012904295697a3d5cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012904295697a3d5cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2603389650","title":"Rigel Pharmaceuticals, Inc.盘中异动 大幅下跌5.27%报37.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603389650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603389650?lang=zh_cn&edition=full","pubTime":"2026-01-14 01:39","pubTimestamp":1768325998,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日01时39分，Rigel Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.27%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Xtl生物制药、Decoy Therapeutics Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Decoy Therapeutics Inc.、Scisparc Ltd.、Xtl生物制药较为活跃，换手率分别为1453.63%、1191.10%、362.21%，振幅较大的相关个股有Xtl生物制药、Lexaria Bioscience Corp C/Wts 14/01/2026 、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为96.62%、67.92%、62.22%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114013959a716bc92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114013959a716bc92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2558666117","title":"Rigel Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.08%报33.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558666117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558666117?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:30","pubTimestamp":1754919044,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时30分，Rigel Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.08%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Lenz Therapeutics, Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.较为活跃，换手率分别为1684.02%、192.33%、75.11%，振幅较大的相关个股有Entero Therapeutics Inc.、Salarius Pharmaceuticals, Inc.、Io Biotech, Inc.，振幅分别为19.46%、8.00%、5.52%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081121304494dcbe5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081121304494dcbe5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2557409520","title":"Rigel Pharmaceuticals, Inc.盘中异动 快速拉升5.12%报32.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557409520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557409520?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:44","pubTimestamp":1754660674,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时44分，Rigel Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.12%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Nucana Plc、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃，换手率分别为198.44%、97.16%、89.07%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cognition Therapeutics, Inc.，振幅分别为45.00%、29.33%、26.50%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808214434973be57c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808214434973be57c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2518614275","title":"Rigel Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.75%报19.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518614275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518614275?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:54","pubTimestamp":1741614856,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时54分，Rigel Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.75%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2864.76%、638.63%、141.33%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021541798a2a2f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021541798a2a2f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2517421161","title":"花旗：维持Rigel Pharmaceuticals(RIGL.US)评级，由买入调整至买入评级, 目标价由49.00美元调整至55.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517421161","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517421161?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:22","pubTimestamp":1741274556,"startTime":"0","endTime":"0","summary":"花旗：维持Rigel Pharmaceuticals(RIGL.US)评级，由买入调整至买入评级, 目标价由49.00美元调整至55.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06232248576365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RIGL"],"gpt_icon":0},{"id":"2517948320","title":"Rigel Pharmaceuticals, Inc.盘中异动 早盘快速下挫8.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948320?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185079,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Rigel Pharmaceuticals, Inc.股票出现波动，股价快速下挫8.49%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为318.54%、251.99%、184.79%，振幅较大的相关个股有Aditxt, Inc.、天境生物、Dianthus Therapeutics, Inc.，振幅分别为23.90%、11.10%、9.87%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223119a260c717&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223119a260c717&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2517983989","title":"Rigel Pharmaceuticals(RIGL.US)：2024年Q4财报实现营收5759.6万美元，前值为3579.2万美元，预期值为5759万美元；每股收益为0.80美元，前值为0.04美元，预期值为0.55美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517983989","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517983989?lang=zh_cn&edition=full","pubTime":"2025-03-05 05:11","pubTimestamp":1741122692,"startTime":"0","endTime":"0","summary":"Rigel Pharmaceuticals(RIGL.US)：2024年Q4财报实现营收5759.6万美元，前值为3579.2万美元，预期值为5759万美元；每股收益为0.80美元，前值为0.04美元，预期值为0.55美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05051148524473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RIGL"],"gpt_icon":0},{"id":"1155217362","title":"Rigel Pharmaceuticals第四季度每股收益$0.80，超出预期$0.47，销售额$57.60M，超出预期$51.73M","url":"https://stock-news.laohu8.com/highlight/detail?id=1155217362","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155217362?lang=zh_cn&edition=full","pubTime":"2025-03-05 05:10","pubTimestamp":1741122639,"startTime":"0","endTime":"0","summary":"Rigel Pharmaceuticals 报告季度每股收益为$0.80，高出分析师预期的$0.47，超出幅度为70.21%。这是较去年同期每股收益$0.04增长了1900%。以上内容来自Benzinga Earnings专栏，原文如下：$Rigel Pharmaceuticals$  reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.47 by 70.21 percent. This is a 1900 percent increase over earnings of $0.04 per share from the same period last year.  The company reported quarterly sales of $57.60 million which beat the analyst consensus estimate of $51.73 million by 11.34 percent.  This is ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Rigel Pharmaceuticals第四季度每股收益$0.80，超出预期$0.47，销售额$57.60M，超出预期$51.73M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RIGL"],"gpt_icon":0},{"id":"2514085743","title":"Rigel Pharmaceuticals, Inc.盘中异动 大幅上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514085743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514085743?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:08","pubTimestamp":1740586113,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时08分，Rigel Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.19%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5651.73%、210.39%、202.73%，振幅较大的相关个股有Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为161.02%、43.31%、41.71%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227000833a2550da8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227000833a2550da8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2513727364","title":"Rigel Pharmaceuticals, Inc.盘中异动 大幅上涨5.53%报21.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727364?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:38","pubTimestamp":1740407923,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时38分，Rigel Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.53%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为55.26%、47.30%、24.53%，振幅较大的相关个股有Pepgen Inc.、Vaxart, Inc. - Common Stock、Gossamer Bio, Inc.，振幅分别为92.70%、21.42%、14.69%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242238449890f78c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242238449890f78c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2510332937","title":"Rigel Pharmaceuticals, Inc.盘中异动 临近午盘大幅下挫5.13%报20.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510332937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510332937?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:00","pubTimestamp":1739293214,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时00分，Rigel Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.13%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.55%。其相关个股中，Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为3007.57%、1338.48%、438.53%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、59.46%、58.60%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212010014961f612e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212010014961f612e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2510653928","title":"Rigel Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.26%报20.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510653928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510653928?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:44","pubTimestamp":1739198644,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时44分，Rigel Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.26%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2016.42%、1139.65%、727.94%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为53.32%、39.80%、39.13%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021022440498807ad0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021022440498807ad0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2509201406","title":"Rigel Pharmaceuticals, Inc.盘中异动 股价大涨5.04%报23.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509201406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509201406?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:53","pubTimestamp":1738860783,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时53分，Rigel Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.04%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Lipella Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025、Palatin Technologies, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为5904.30%、1567.01%、158.59%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Palatin Technologies, Inc.，振幅分别为125.58%、53.02%、49.54%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207005303987ca487&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207005303987ca487&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2509235876","title":"Rigel Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.11%报21.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509235876","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509235876?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:01","pubTimestamp":1738771303,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时01分，Rigel Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.11%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.29%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4203.78%、1492.21%、1274.54%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为96.10%、59.80%、54.05%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206000143987b8c4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206000143987b8c4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2508149798","title":"Rigel Pharmaceuticals, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508149798?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:31","pubTimestamp":1738593115,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时31分，Rigel Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.08%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为313.51%、209.90%、126.36%，振幅较大的相关个股有Hcw Biologics Inc.、Briacell Therapeutics Corp.、Tc Biopharm  Plc，振幅分别为14.02%、11.95%、11.75%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223155a2380944&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223155a2380944&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2508999368","title":"Rigel Pharmaceuticals, Inc.盘中异动 下午盘急速跳水5.62%报21.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508999368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508999368?lang=zh_cn&edition=full","pubTime":"2025-02-01 02:59","pubTimestamp":1738349974,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日02时59分，Rigel Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.62%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Metsera, Inc.、Seastar Medical Holding Corporation涨幅较大，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Silexion Therapeutics Corp较为活跃，换手率分别为2736.79%、2028.61%、200.07%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Seastar Medical Holding Corporation，振幅分别为121.11%、80.00%、69.36%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201025934a23570e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201025934a23570e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2504160402","title":"Rigel Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504160402","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504160402?lang=zh_cn&edition=full","pubTime":"2025-01-17 23:00","pubTimestamp":1737126043,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日23时00分，Rigel Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.13%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117230043986a1cd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117230043986a1cd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2503164046","title":"Rigel Pharmaceuticals, Inc.盘中异动 股价大涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503164046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503164046?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:48","pubTimestamp":1736952494,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时48分，Rigel Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.57%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Os Therapies Incorporated涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Os Therapies Incorporated较为活跃，换手率分别为194.50%、104.75%、66.21%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Os Therapies Incorporated、Eterna Therapeutics Inc.，振幅分别为50.00%、46.88%、23.73%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115224814a22302bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115224814a22302bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rigel.com","stockEarnings":[{"period":"1week","weight":0.0332},{"period":"1month","weight":-0.0579},{"period":"3month","weight":-0.2327},{"period":"6month","weight":-0.1455},{"period":"1year","weight":0.7024},{"period":"ytd","weight":-0.1721}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rigel Pharmaceuticals, Inc.于1996年6月14日成立于特拉华州。该公司是一家生物技术公司，致力于发现、开发和提供新疗法，显著改善血液系统疾病和癌症患者的生活。公司首个获FDA批准的产品是TAVALISSE（六水二钠福司他马替尼）片，这是唯一获批的口服脾脏酪氨酸激酶（SYK）抑制剂，用于治疗对先前治疗反应不足的慢性免疫性血小板减少症（ITP）成人患者。该公司第二个获得FDA批准的产品是REZLIDHIA（olutasidenib）胶囊，用于治疗经FDA批准的试验检测出具有易感异柠檬酸脱氢酶-1（IDH1）突变的复发或难治性（R/R）急性髓系白血病（AML）成人患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.384615,"avgChangeRate":-0.021118},{"month":2,"riseRate":0.461538,"avgChangeRate":-0.029475},{"month":3,"riseRate":0.52,"avgChangeRate":0.012689},{"month":4,"riseRate":0.52,"avgChangeRate":0.027992},{"month":5,"riseRate":0.32,"avgChangeRate":-0.001796},{"month":6,"riseRate":0.4,"avgChangeRate":0.007899},{"month":7,"riseRate":0.52,"avgChangeRate":0.000931},{"month":8,"riseRate":0.44,"avgChangeRate":0.03711},{"month":9,"riseRate":0.48,"avgChangeRate":0.019365},{"month":10,"riseRate":0.4,"avgChangeRate":-0.057423},{"month":11,"riseRate":0.44,"avgChangeRate":0.081471},{"month":12,"riseRate":0.461538,"avgChangeRate":0.119534}],"exchange":"NASDAQ","name":"Rigel Pharmaceuticals","nameEN":"Rigel Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rigel Pharmaceuticals(RIGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rigel Pharmaceuticals(RIGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rigel Pharmaceuticals,RIGL,Rigel Pharmaceuticals股票,Rigel Pharmaceuticals股票老虎,Rigel Pharmaceuticals股票老虎国际,Rigel Pharmaceuticals行情,Rigel Pharmaceuticals股票行情,Rigel Pharmaceuticals股价,Rigel Pharmaceuticals股市,Rigel Pharmaceuticals股票价格,Rigel Pharmaceuticals股票交易,Rigel Pharmaceuticals股票购买,Rigel Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rigel Pharmaceuticals(RIGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rigel Pharmaceuticals(RIGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况